GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (NAS:GRFS) » Definitions » 3-Year EPS without NRI Growth Rate

GRFS (Grifols) 3-Year EPS without NRI Growth Rate : -45.00% (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Grifols 3-Year EPS without NRI Growth Rate?

Grifols's EPS without NRI for the three months ended in Jun. 2024 was $0.03.

During the past 12 months, Grifols's average EPS without NRI Growth Rate was 43.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -45.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -32.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was -11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Grifols was 86.80% per year. The lowest was -45.00% per year. And the median was 6.00% per year.


Competitive Comparison of Grifols's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - General subindustry, Grifols's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grifols's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Grifols's 3-Year EPS without NRI Growth Rate falls into.



Grifols 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Grifols  (NAS:GRFS) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Grifols 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Grifols's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Grifols Business Description

Industry
Address
Avinguda de la Generalitat, 152, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.